Sparian Biosciences Inc. has been awarded a $19.5 million, 5-year grant to fund development of SBS-226 from IND submission through phase I development. SBS-226 is a first-in-class dual μ-opioid ...
The AHA’s Bridge to Care initiative highlights how hospitals and health systems are strengthening care transitions and supporting ongoing treatment engagement for patients with opioid use disorder and ...
Zhanette Coffee, Ph.D., MSN, APRN, spent years working as an advanced practice nurse with certifications in family practice and addictions nursing and saw firsthand the challenges faced not only by ...
Access to medications for opioid use disorder (OUD) in the pharmacy is internationally accepted; however, in the US, methadone treatment for OUD can only be provided by opioid treatment programs (OTPs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results